Follow Chr. Hansen A/S

Press releases

Chr. Hansen and Lonza’s newly branded joint venture, BacThera, receives anti-trust approvals to start contract manufacturing of live biotherapeutic products

Chr. Hansen and Lonza’s newly branded joint venture, BacThera, receives anti-trust approvals to start contract manufacturing of live biotherapeutic products

Press releases   •   Aug 29, 2019 13:52 UTC

​Chr. Hansen Holding A/S, a leading global bioscience company, and Lonza AG, a leading pharma contract manufacturing company, announce today that they have received the relevant approvals from anti-trust regulators needed to establish the 50/50 joint venture in the emerging market for live biotherapeutic products, which was originally announced in Company Announcement No. 04 on April 2, 2019.

Chr. Hansen gearer op til en bæredygtig fremtid

Chr. Hansen gearer op til en bæredygtig fremtid

Press releases   •   Aug 29, 2019 07:39 UTC

Den globale bioscience virksomhed udvider og styrker forskning- & udviklingsfaciliteterne i Hørsholm for at imødekomme den stigende efterspørgsel efter naturlige og bæredygtige produkter.

Chr. Hansen gears up for a sustainable future

Chr. Hansen gears up for a sustainable future

Press releases   •   Aug 29, 2019 07:38 UTC

Global bioscience company Chr. Hansen to expand and strengthen its research & development facilities north of Copenhagen to meet the increasing demand for natural and sustainable products.

Endnu en influenzasæson er på trapperne, men ny forskning har afsløret et hemmeligt våben, der kan nedbringe omkostningerne ved influenza-lignende sygdom

Endnu en influenzasæson er på trapperne, men ny forskning har afsløret et hemmeligt våben, der kan nedbringe omkostningerne ved influenza-lignende sygdom

Press releases   •   Aug 28, 2019 07:48 UTC

En ny sundhedsøkonomisk undersøgelse har påvist, at indtagelsen af probiotika kan bidrage til at reducere omkostningerne forbundet med influenza-lignende sygdom. Alene i USA kan indtagelsen af probiotika nedbringe antallet af sygedage med over 54 millioner dage om året, ifølge undersøgelsen.

As the dreaded flu-season knocks on our door, a new study reveals a secret weapon to reduce the cost of flu-like sickness

As the dreaded flu-season knocks on our door, a new study reveals a secret weapon to reduce the cost of flu-like sickness

Press releases   •   Aug 28, 2019 07:22 UTC

A new health economics study shows that the intake of probiotics can help reduce the cost of flu-like sickness. In the US alone, taking probiotics can reduce the number of sick days by over 54 million days per year, according to the study.

Solid sales growth and profitability in Q3, but reduced organic growth outlook for the year

Solid sales growth and profitability in Q3, but reduced organic growth outlook for the year

Press releases   •   Jun 26, 2019 17:57 UTC

Chr. Hansen delivers a solid financial result of 9% organic growth for the first nine months, but adjusts full-year organic growth​ outlook from 9-11% to 7-8%

Groundbreaking ‘sweet’ culture reduces added sugar in fermented dairy products

Groundbreaking ‘sweet’ culture reduces added sugar in fermented dairy products

Press releases   •   May 08, 2019 08:40 UTC

Chr. Hansen launches Sweety® Y-1: The first culture in the world allowing dairy manufacturers to create naturally sweeter products while reducing added sugar

Game-changing coagulant enables up to one percent yield increase

Game-changing coagulant enables up to one percent yield increase

Press releases   •   Apr 03, 2019 07:17 UTC

Chr. Hansen launches CHY-MAX® Supreme - the most precise and innovative coagulant on the market with superior functionality for modern cheesemakers

Solid momentum continues: 9% organic growth in the first 6 months of 2018/19

Solid momentum continues: 9% organic growth in the first 6 months of 2018/19

Press releases   •   Apr 03, 2019 06:08 UTC

Solid momentum continues: 9% organic growth in the first 6 months of 2018/19 Chr. Hansen delivers solid half-year result of 9% organic growth and maintains overall outlook for the full year. The growth comes from all business areas: Food Cultures & Enzymes 10%, Health & Nutrition 11% and Natural Colors 5%

World’s best documented probiotic now available for fermented plant bases

World’s best documented probiotic now available for fermented plant bases

Press releases   •   Feb 28, 2019 14:44 UTC

Chr. Hansen launches nu-trish® LGG® DA to further improve the health appeal of fermented plant bases